NCT00806065View on ClinicalTrials.gov

Study of ENMD-2076 in Patients With Multiple Myeloma

PHASE1CompletedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

December 31, 2008

Primary Completion Date

November 30, 2011

Study Completion Date

January 31, 2012

Conditions
Multiple Myeloma
Interventions
DRUG

ENMD-2076

Trial Locations (1)

46202

Indiana University Melvin and Bren Simon Cancer Center, Indianapolis

Sponsors
All Listed Sponsors
lead

CASI Pharmaceuticals, Inc.

INDUSTRY